There are about 7,500 projects under development by pharmaceutical and biotechnology companies worldwide, and an estimated 80,000 clinical trials are conducted globally every year. Today, 80% of these clinical trials are funded by private industry rather than by government, according to published reports.
With so many potential drugs under review, there is huge pressure to be first to market. Therefore pharmaceutical companies look to improve every phase of drug development — from new approaches to discovery, to identifying therapeutic targets that optimize core competencies, and finally to moving compounds more quickly into and through better-designed global clinical trials. To ensure top-quality trials, companies need to provide more staff training, adopt technology platforms, and understand the critical importance of appropriate inclusion/exclusion criteria.
The need to conduct faster trials has encouraged pharmaceutical companies to turn to outside contractors, which are acting as partners to shorten…
Blurring the Lines
Academic Medical Centers
Experts on this topic
Acurian Inc. Horsham, Pa.; Acurian is a leading provider of clinical-trial patient and investigator recruitment solutions for the pharmaceutical and biotechnology industries.
Association of Clinical Research Professionals. Washington, D.C.; ACRP is an international membership organization that represents more than 16,000 clinical research professionals from diverse organizations
Cynthia M. Dunn, M.D. VP of Operations, Western Institutional Review Board, Olympia, Wash.; WIRB, the oldest independent IRB in America, provides review services in more than 30 countries and in all 50 states
Scott Grisanti. Senior VP of Business Development, eResearchTechnology Inc., Philadelphia. eResearch is a business-to-business provider of integrated technology-based products and services to the pharmaceutical, medical device, and biotechnological industries
Cary Garner. VP, Global Clinical Research Unit, Parexel International Corp., Waltham, Mass.; Parexel is a leading contract research organization
Ken Getz. President & CEO, CenterWatch Inc., Boston; CenterWatch is a publishing and information services company focusing on the clinical-trials industry
Mark A. Goldberg, M.D. President, Perceptive Informatics Inc., Waltham, Mass.; Perceptive Informatics is the information technology subsidiary of Parexel International Corp.
John J. Schickling. Chief Financial Officer, Phase Forward Inc., Waltham, Mass. Phase Forward offers e-process solutions for accelerating global pharmaceutical development
The U.S. National Institutes of Health. Bethesda, Md., through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members, and members of the public with current information about clinical research studies
Joe Avellone, M.D. CEO, Veritas Medicine Inc. Cambridge, Mass. Veritas is an online health resource focused on improving patient access to clinical trials and information about therapies in development for serious medical conditions